Product Information
DEXAMETHASONE 0.5 MG/5 ML ELX is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1050 per ML under NDC 64980050924. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 12, 2011. Its Orange Book therapeutic-equivalence code is AA.
Strength
.5 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980050924
Classification
Generic
Dosage Form
ELIXIR
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA090891FDA Approved
7/12/2011
TE Code
AA
On Market Since
8/1/2011
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 0.5 MG/5 ML ELX has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1050 per ML |
|---|---|
| All-time high | $0.1838 (Nov 12, 2014) |
| All-time low | $0.0710 (Nov 20, 2024) |
| 52-week high | $0.1096 |
| 52-week low | $0.0944 |
| Median price | $0.1078 |
| Average price | $0.1242 |
| Largest weekly change | -38.6% (Sep 19, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 0.5 MG/5 ML ELX?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 0.5 MG/5 ML ELX, manufactured by Rising Pharma Holdings Inc., is $0.1050 per ML (NDC 64980050924), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 0.5 MG/5 ML ELX changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 0.5 MG/5 ML ELX has declined 42.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 0.5 MG/5 ML ELX?
Since Nov 28, 2013, the NADAC for DEXAMETHASONE 0.5 MG/5 ML ELX has ranged from a low of $0.0710 (Nov 20, 2024) to a high of $0.1838 (Nov 12, 2014), with a median of $0.1078 per ML.
Are there cheaper alternatives to DEXAMETHASONE 0.5 MG/5 ML ELX?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXAMETHASONE 0.5 MG/5 ML ELX in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXAMETHASONE 0.5 MG/5 ML ELX?
DEXAMETHASONE 0.5 MG/5 ML ELX (NDC 64980050924) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.